Imatinib Mesylate Tablets Market, Global Outlook and Forecast 2024-2031

Report ID: 1658289 | Published Date: Jan 2025 | No. of Page: 60 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Imatinib Mesylate Tablets Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Imatinib Mesylate Tablets Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Imatinib Mesylate Tablets Overall Market Size
    2.1 Global Imatinib Mesylate Tablets Market Size: 2021 VS 2028
    2.2 Global Imatinib Mesylate Tablets Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Imatinib Mesylate Tablets Players in Global Market
    3.2 Top Global Imatinib Mesylate Tablets Companies Ranked by Revenue
    3.3 Global Imatinib Mesylate Tablets Revenue by Companies
    3.4 Top 3 and Top 5 Imatinib Mesylate Tablets Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Imatinib Mesylate Tablets Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Imatinib Mesylate Tablets Players in Global Market
        3.6.1 List of Global Tier 1 Imatinib Mesylate Tablets Companies
        3.6.2 List of Global Tier 2 and Tier 3 Imatinib Mesylate Tablets Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Imatinib Mesylate Tablets Market Size Markets, 2021 & 2028
        4.1.2 100 mg
        4.1.3 400 mg
    4.2 By Type - Global Imatinib Mesylate Tablets Revenue & Forecasts
        4.2.1 By Type - Global Imatinib Mesylate Tablets Revenue, 2017-2022
        4.2.2 By Type - Global Imatinib Mesylate Tablets Revenue, 2023-2028
        4.2.3 By Type - Global Imatinib Mesylate Tablets Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Imatinib Mesylate Tablets Market Size, 2021 & 2028
        5.1.2 Hospital
        5.1.3 Clinics
    5.2 By Application - Global Imatinib Mesylate Tablets Revenue & Forecasts
        5.2.1 By Application - Global Imatinib Mesylate Tablets Revenue, 2017-2022
        5.2.2 By Application - Global Imatinib Mesylate Tablets Revenue, 2023-2028
        5.2.3 By Application - Global Imatinib Mesylate Tablets Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Imatinib Mesylate Tablets Market Size, 2021 & 2028
    6.2 By Region - Global Imatinib Mesylate Tablets Revenue & Forecasts
        6.2.1 By Region - Global Imatinib Mesylate Tablets Revenue, 2017-2022
        6.2.2 By Region - Global Imatinib Mesylate Tablets Revenue, 2023-2028
        6.2.3 By Region - Global Imatinib Mesylate Tablets Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Imatinib Mesylate Tablets Revenue, 2017-2028
        6.3.2 US Imatinib Mesylate Tablets Market Size, 2017-2028
        6.3.3 Canada Imatinib Mesylate Tablets Market Size, 2017-2028
        6.3.4 Mexico Imatinib Mesylate Tablets Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Imatinib Mesylate Tablets Revenue, 2017-2028
        6.4.2 Germany Imatinib Mesylate Tablets Market Size, 2017-2028
        6.4.3 France Imatinib Mesylate Tablets Market Size, 2017-2028
        6.4.4 U.K. Imatinib Mesylate Tablets Market Size, 2017-2028
        6.4.5 Italy Imatinib Mesylate Tablets Market Size, 2017-2028
        6.4.6 Russia Imatinib Mesylate Tablets Market Size, 2017-2028
        6.4.7 Nordic Countries Imatinib Mesylate Tablets Market Size, 2017-2028
        6.4.8 Benelux Imatinib Mesylate Tablets Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Imatinib Mesylate Tablets Revenue, 2017-2028
        6.5.2 China Imatinib Mesylate Tablets Market Size, 2017-2028
        6.5.3 Japan Imatinib Mesylate Tablets Market Size, 2017-2028
        6.5.4 South Korea Imatinib Mesylate Tablets Market Size, 2017-2028
        6.5.5 Southeast Asia Imatinib Mesylate Tablets Market Size, 2017-2028
        6.5.6 India Imatinib Mesylate Tablets Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Imatinib Mesylate Tablets Revenue, 2017-2028
        6.6.2 Brazil Imatinib Mesylate Tablets Market Size, 2017-2028
        6.6.3 Argentina Imatinib Mesylate Tablets Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Imatinib Mesylate Tablets Revenue, 2017-2028
        6.7.2 Turkey Imatinib Mesylate Tablets Market Size, 2017-2028
        6.7.3 Israel Imatinib Mesylate Tablets Market Size, 2017-2028
        6.7.4 Saudi Arabia Imatinib Mesylate Tablets Market Size, 2017-2028
        6.7.5 UAE Imatinib Mesylate Tablets Market Size, 2017-2028
7 Players Profiles
    7.1 Teva Pharmaceuticals
        7.1.1 Teva Pharmaceuticals Corporate Summary
        7.1.2 Teva Pharmaceuticals Business Overview
        7.1.3 Teva Pharmaceuticals Imatinib Mesylate Tablets Major Product Offerings
        7.1.4 Teva Pharmaceuticals Imatinib Mesylate Tablets Revenue in Global Market (2017-2022)
        7.1.5 Teva Pharmaceuticals Key News
    7.2 Hikma Pharmaceuticals
        7.2.1 Hikma Pharmaceuticals Corporate Summary
        7.2.2 Hikma Pharmaceuticals Business Overview
        7.2.3 Hikma Pharmaceuticals Imatinib Mesylate Tablets Major Product Offerings
        7.2.4 Hikma Pharmaceuticals Imatinib Mesylate Tablets Revenue in Global Market (2017-2022)
        7.2.5 Hikma Pharmaceuticals Key News
    7.3 Apotex Inc
        7.3.1 Apotex Inc Corporate Summary
        7.3.2 Apotex Inc Business Overview
        7.3.3 Apotex Inc Imatinib Mesylate Tablets Major Product Offerings
        7.3.4 Apotex Inc Imatinib Mesylate Tablets Revenue in Global Market (2017-2022)
        7.3.5 Apotex Inc Key News
    7.4 Sun Pharmaceutical Industries
        7.4.1 Sun Pharmaceutical Industries Corporate Summary
        7.4.2 Sun Pharmaceutical Industries Business Overview
        7.4.3 Sun Pharmaceutical Industries Imatinib Mesylate Tablets Major Product Offerings
        7.4.4 Sun Pharmaceutical Industries Imatinib Mesylate Tablets Revenue in Global Market (2017-2022)
        7.4.5 Sun Pharmaceutical Industries Key News
    7.5 Lupin Limited
        7.5.1 Lupin Limited Corporate Summary
        7.5.2 Lupin Limited Business Overview
        7.5.3 Lupin Limited Imatinib Mesylate Tablets Major Product Offerings
        7.5.4 Lupin Limited Imatinib Mesylate Tablets Revenue in Global Market (2017-2022)
        7.5.5 Lupin Limited Key News
    7.6 Natco Pharma
        7.6.1 Natco Pharma Corporate Summary
        7.6.2 Natco Pharma Business Overview
        7.6.3 Natco Pharma Imatinib Mesylate Tablets Major Product Offerings
        7.6.4 Natco Pharma Imatinib Mesylate Tablets Revenue in Global Market (2017-2022)
        7.6.5 Natco Pharma Key News
    7.7 Getwell Oncology
        7.7.1 Getwell Oncology Corporate Summary
        7.7.2 Getwell Oncology Business Overview
        7.7.3 Getwell Oncology Imatinib Mesylate Tablets Major Product Offerings
        7.7.4 Getwell Oncology Imatinib Mesylate Tablets Revenue in Global Market (2017-2022)
        7.7.5 Getwell Oncology Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Imatinib Mesylate Tablets Market Opportunities & Trends in Global Market
    Table 2. Imatinib Mesylate Tablets Market Drivers in Global Market
    Table 3. Imatinib Mesylate Tablets Market Restraints in Global Market
    Table 4. Key Players of Imatinib Mesylate Tablets in Global Market
    Table 5. Top Imatinib Mesylate Tablets Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Imatinib Mesylate Tablets Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Imatinib Mesylate Tablets Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Imatinib Mesylate Tablets Product Type
    Table 9. List of Global Tier 1 Imatinib Mesylate Tablets Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Imatinib Mesylate Tablets Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Imatinib Mesylate Tablets Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Imatinib Mesylate Tablets Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Imatinib Mesylate Tablets Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Imatinib Mesylate Tablets Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Imatinib Mesylate Tablets Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Imatinib Mesylate Tablets Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Imatinib Mesylate Tablets Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Imatinib Mesylate Tablets Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Imatinib Mesylate Tablets Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Imatinib Mesylate Tablets Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Imatinib Mesylate Tablets Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Imatinib Mesylate Tablets Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Imatinib Mesylate Tablets Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Imatinib Mesylate Tablets Revenue, (US$, Mn), 2023-2028
    Table 30. Teva Pharmaceuticals Corporate Summary
    Table 31. Teva Pharmaceuticals Imatinib Mesylate Tablets Product Offerings
    Table 32. Teva Pharmaceuticals Imatinib Mesylate Tablets Revenue (US$, Mn), (2017-2022)
    Table 33. Hikma Pharmaceuticals Corporate Summary
    Table 34. Hikma Pharmaceuticals Imatinib Mesylate Tablets Product Offerings
    Table 35. Hikma Pharmaceuticals Imatinib Mesylate Tablets Revenue (US$, Mn), (2017-2022)
    Table 36. Apotex Inc Corporate Summary
    Table 37. Apotex Inc Imatinib Mesylate Tablets Product Offerings
    Table 38. Apotex Inc Imatinib Mesylate Tablets Revenue (US$, Mn), (2017-2022)
    Table 39. Sun Pharmaceutical Industries Corporate Summary
    Table 40. Sun Pharmaceutical Industries Imatinib Mesylate Tablets Product Offerings
    Table 41. Sun Pharmaceutical Industries Imatinib Mesylate Tablets Revenue (US$, Mn), (2017-2022)
    Table 42. Lupin Limited Corporate Summary
    Table 43. Lupin Limited Imatinib Mesylate Tablets Product Offerings
    Table 44. Lupin Limited Imatinib Mesylate Tablets Revenue (US$, Mn), (2017-2022)
    Table 45. Natco Pharma Corporate Summary
    Table 46. Natco Pharma Imatinib Mesylate Tablets Product Offerings
    Table 47. Natco Pharma Imatinib Mesylate Tablets Revenue (US$, Mn), (2017-2022)
    Table 48. Getwell Oncology Corporate Summary
    Table 49. Getwell Oncology Imatinib Mesylate Tablets Product Offerings
    Table 50. Getwell Oncology Imatinib Mesylate Tablets Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Imatinib Mesylate Tablets Segment by Type in 2021
    Figure 2. Imatinib Mesylate Tablets Segment by Application in 2021
    Figure 3. Global Imatinib Mesylate Tablets Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Imatinib Mesylate Tablets Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Imatinib Mesylate Tablets Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Imatinib Mesylate Tablets Revenue in 2021
    Figure 8. By Type - Global Imatinib Mesylate Tablets Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Imatinib Mesylate Tablets Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Imatinib Mesylate Tablets Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Imatinib Mesylate Tablets Revenue Market Share, 2017-2028
    Figure 12. US Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Imatinib Mesylate Tablets Revenue Market Share, 2017-2028
    Figure 16. Germany Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
    Figure 17. France Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Imatinib Mesylate Tablets Revenue Market Share, 2017-2028
    Figure 24. China Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
    Figure 28. India Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Imatinib Mesylate Tablets Revenue Market Share, 2017-2028
    Figure 30. Brazil Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Imatinib Mesylate Tablets Revenue Market Share, 2017-2028
    Figure 33. Turkey Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Imatinib Mesylate Tablets Revenue, (US$, Mn), 2017-2028
    Figure 37. Teva Pharmaceuticals Imatinib Mesylate Tablets Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Hikma Pharmaceuticals Imatinib Mesylate Tablets Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Apotex Inc Imatinib Mesylate Tablets Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Sun Pharmaceutical Industries Imatinib Mesylate Tablets Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Lupin Limited Imatinib Mesylate Tablets Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Natco Pharma Imatinib Mesylate Tablets Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Getwell Oncology Imatinib Mesylate Tablets Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
60
Frequently Asked Questions
Imatinib Mesylate Tablets Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Imatinib Mesylate Tablets Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Imatinib Mesylate Tablets Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports